CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keegan, T. H.M.
Right arrow Articles by Ambinder, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keegan, T. H.M.
Right arrow Articles by Ambinder, R. F.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1095-1101, June 2006
© 2006 American Association for Cancer Research

Body Size, Physical Activity, and Risk of Hodgkin's Lymphoma in Women

Theresa H.M. Keegan1, Sally L. Glaser1, Christina A. Clarke1, Ronald F. Dorfman2, Risa B. Mann3, Joseph A. DiGiuseppe4, Ellen T. Chang1 and Richard F. Ambinder3

1 Northern California Cancer Center, Fremont, California; 2 Stanford University Medical Center, Stanford, California; 3 Johns Hopkins University, Baltimore, Maryland; and 4 Hartford Hospital, Hartford, Connecticut

Requests for reprints: Theresa H.M. Keegan, Northern California Cancer Center, Suite 300, 2201 Walnut Avenue, Fremont, CA 94538-2334. Phone: 510-608-5040; Fax: 510-608-5095. E-mail: tkeegan{at}nccc.org


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Few studies have examined the associations of body size and physical activity with the development of Hodgkin's lymphoma (HL) in women. In data from a population-based case-control study in women ages 19 to 79 years, we assessed the relation of self-report height, weight, body mass index (BMI), and strenuous physical activity to HL risk in 312 cases with diagnostic re-review and 325 random-digit dialed controls using logistic regression. Analyses were stratified by age group and tumor cell presence of EBV. After adjustment for social class measures, taller childhood and adult height were associated with higher HL risk. In women ages 19 to 44 years, HL risk was elevated for higher, but healthy, BMI values, whereas in women ages 45 to 79 years, associations with BMI were inverse. The odds of developing HL were lower with participation (versus nonparticipation) in strenuous physical activity in the past year [odds ratio (OR), 0.58; 95% confidence interval (95% CI), 0.39-0.87 in women 19-44 years; OR, 0.45; 95% CI, 0.19-1.06 in women 45-79 years] and throughout adult life, and with sports team membership (versus nonmembership) in high school and/or at ages 18 to 22 years. Results were similar in cases (n = 269) with and without tumor-cell EBV compared with controls, although the inverse association with physical activity was somewhat stronger for women with EBV-positive disease. These findings show that in women, body size and strenuous physical activity, both modifiable characteristics, are associated with HL risk in adult life possibly through immunologic, infectious, or genetic mechanisms. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1095–101)


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Hodgkin's lymphoma (HL) is a lymphoid malignancy that is one of the most common cancers of young adults (1). Although its etiology is far from established, epidemiologic studies have implicated an infectious precursor, EBV (2, 3), as well as identified generally consistent associations with higher social class, selected reproductive factors, familial aggregation, genetic factors, and certain occupations (2-4). Scattered studies have suggested that taller height (5-8) and higher body mass index (BMI) in men (9, 10), but not women (10-12), affect risk of HL. Furthermore, in the single previous study of physical activity and HL risk, participation in intramural or varsity sports ≥5 hours per week early in college was associated with a nonsignificantly reduced risk of HL (13). Body size and physical activity, shown to be related to various malignancies including other lymphomas (10, 14, 15), are known to influence immune function (16-18), which is likely critical in HL etiology. Thus, a role of these factors in HL development would be consistent with its epidemiology as currently understood. However, few prior HL studies examined these associations in detail or with attention to social class confounding, and data have been particularly limited for women.

The objective of this study was to assess the relation of height, weight, BMI, and strenuous physical activity to the development of HL in women using data from a population-based case-control study of the effect of reproductive factors on HL risk.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
For the case-control study, detailed elsewhere (4, 19, 20), the population-based Greater Bay Area Cancer Registry identified 395 women ages 19 to 79 years and living in the Greater Bay Area of northern California when newly diagnosed with HL between mid July 1988 and the end of December 1994. Institutional review boards at the Northern California Cancer Center and Stanford University approved this project and its informed consent procedures. Among the 377 eligible HL patients (i.e., those alive at report to the registry), 320 (85%) were interviewed. Response rates were lower in women over age 54 years (53%), primarily due to mortality. The median time from diagnosis to interview for cases was 13 months, as it generally took ~12 months for cases to be reported to the cancer registry. Histopathologic re-review confirmed that 312 patients had HL, and these women were included in this study. They were predominantly young (mean age at diagnosis = 35.0 years) and composed of 251 non-Hispanic whites (80%), 26 blacks (8%), 18 Hispanics (6%), and 17 Asians (5%). Controls were women without a history of HL, living in the same geographic area, identified through random-digit dialing, and frequency matched to cases on 5-year age group and race/ethnicity; of the 450 invited into the study, 325 (72%) participated.

Subjects were interviewed with a standardized instrument in person or by phone (for the 30 women who had moved out of the area) about reproductive factors and exposure to exogenous hormones, as well as about social class characteristics considered potential confounders for these associations, for a reference period corresponding to the year before diagnosis for cases and the same time before interview for controls. In addition, subjects were asked to estimate their height relative to their peers (taller, the same, or shorter) at ages 8 and 12 years, their height in feet and inches at age 21 years, or at interview if 19 to 20 years old, and their weight in pounds and ounces at birth and at the reference period. Birth weight was missing for 21% of subjects ages 19 to 44 years and 36% of subjects ages 45 to 79 years; women with missing data were more likely to be non-white but did not differ on any other characteristic measured including case-control status, presence of EBV in HL tumors, and the body size/physical activity variables (as described below). As regards physical activity, each subject was asked about the annual number of months (none, 1-3, 4-6, 7-9, or 10-12) she participated in strenuous physical activities or sports that caused her "to get out of breath or to work up a sweat" at least twice weekly during high school, from ages 18 through 22 years, at ages 25, 35, and 50 years, and at the reference period. For each time period, the referent group included women who were inactive at that time period. Subjects also were asked whether they participated as a member of a sports team or group (outside of physical education classes) in high school and/or from ages 18 through 22 years. The physical activity questions were taken from an instrument used by the College Alumni Health Study (21).

Adult height and weight at the reference period (converted to meters and kilograms) were categorized into quartiles based on distributions in the control group and combined to create BMI (kg/m2); obesity was defined as a BMI >30.0 kg/m2 and overweight was defined as 25.0 to 29.9 kg/m2 based on the WHO designations (22). Because most young adult subjects had BMIs in the reference range (<25.0 kg/m2), we also considered quartiles of BMI based on the distribution of controls in this age group. To summarize strenuous physical activity throughout adulthood, we categorized women as "active" if they participated in strenuous physical activities or sports at least twice a week for at least 1 month per year at all of the times queried, and inactive otherwise.

EBV, an established oncogenic herpesvirus, has been detected in the tumor cells of some HL patients (2, 3, 23), and HL epidemiology varies by EBV tumor-cell presence (24-26). Therefore, we (R.F.A., R.B.M., and J.AD.) tested for tumor-cell EBV using in situ hybridization for EBV RNA (EBER1), with positive and negative controls, and standard immunohistochemical assays for EBV protein (LMP1), as described elsewhere (27, 28), in paraffin-embedded tissue sections from the 311 HL patients (79% of 395) for whom usable pathology specimens could be retrieved. Among the 269 patients with known EBV tumor status and interview data, and therefore eligible for inclusion in these analyses, 37 (14%) had EBV-positive tumors, including 11% of women ages <45 years and 23% of women ages ≥45 years; 11% of non-Hispanic whites and 25% of all others; and 10% of the nodular sclerosis histologic subtype cases and 43% of mixed cellularity cases.

Statistical Analysis
Associations between HL and each body size and physical activity measure were first examined by descriptive statistics, including quartiles for continuous variables. These analyses were stratified by age at diagnosis grouped as 19 to 44 years (young adults) and 45 to 79 years (older adults), on the basis of regional age-specific incidence patterns, and showed differences in risk factor patterns (1, 19, 20). Within each of these two age groups, data were further examined by tumor EBV presence, race/ethnicity, and other factors. Using unconditional logistic regression, we computed odds ratios (OR) and corresponding 95% confidence intervals (95% CI) to estimate relative risks of HL associated with each variable under study. The ORs were adjusted for variables previously determined to be associated with HL (4, 19, 20, 29); these included age in years, race/ethnicity (white, nonwhite), cigarette smoking 1 year before diagnosis/interview (current, former, never), ever having nursed children, number of miscarriages (0, 1, and 2+), having a first- or second-degree family history of lymphoma, Jewish heritage, having a single room at age 11 years, and living in a rented family home at age 8 years. Heterogeneity between age groups was assessed with a Wald test of the significance of an interaction term between age group (young or older) and each variable of interest, coded categorically. Monotonic trends were assessed with a Wald test of the significance of the variable of interest coded ordinally using the median value of each category.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Body Size
Among young adult women, 73% of cases and 63% of controls providing birth weight data had a self-reported birth weight <3.6 kg. At the reference period, cases and controls had mean weights of 63.8 and 62.8 kg, respectively, and mean heights of 1.66 and 1.65 m, respectively. For 76% of cases and 79% of controls, BMI was in the reference range. Table 1 shows that, for young adults, weight was related to risk of HL suggestively at birth, even after adjustment for BMI (data not shown), but not in adulthood after adjustment for height. In contrast, taller height in childhood and adulthood were related to HL, even after control for various socioeconomic measures and for adult weight (the latter data not shown). Risk of HL was nonsignificantly increased for women who reported being the same height as or taller than most other girls at age 12 years, as compared with being shorter; results were similar for height at age 8 years (data not shown). Adult height in the third and fourth quartiles compared with the first quartile was linked to an increased risk of HL. Similarly, women in higher BMI quartiles, particularly the second and fourth quartiles, had increased risks of HL compared with women in the first quartile of BMI. Being overweight at the reference period also was marginally associated with increased risk of HL (P = 0.07). Being obese was not associated with HL risk, although these findings were based on only 19 obese cases and 22 obese controls.


View this table:
[in this window]
[in a new window]
  		Table 1. Adjusted ORs (95% CIs) for the association between height and weight and risk of Hodgkin's lymphoma among women 19 to 44 and 45 to 79 years of age

 
Among older women, 68% of cases and 86% of controls providing birth weight data had a birth weight of <3.6 kg. At the reference period, cases and controls had mean weights of 68.8 and 68.3 kg, respectively, and mean heights of 1.65 and 1.64 m, respectively. For 66% of cases and 52% of controls, BMI was in the reference range. Table 1 shows that, in this older age group, the risk of HL was significantly reduced for women at higher weight at birth, even after adjustment for baseline BMI (data not shown), and lower, albeit not significantly, for heavier women in adulthood after adjustment for height. However, the relationships between HL and birth weight or adult weight were not significantly different from the relationships in younger women, likely due to the small numbers of older adults. In older adults, height in childhood and in adulthood showed associations with HL similar to those in young adults, although none were statistically significant. Higher BMI was associated with a lower risk of HL, but again not significantly. Being overweight, but not obese, compared with having a normal weight at the reference period was associated with a lower risk of HL. The relationship of being overweight, versus normal weight, with risk of HL was significantly different between older and younger women (P = 0.02).

Physical Activity
Among young adult women, being strenuously physically active throughout adult life was associated with a nonsignificantly reduced risk for HL whereas participating in strenuous physical activity at least twice a week for ≥1 months before the reference period led to an ~40% reduction in the odds of HL (Table 2 ). Among women who reported exercising strenuously before the reference period, the largest single proportion (49%) exercised for 10 to 12 months per year; the risk of HL was similarly reduced for women who participated in strenuous physical activity for varying amounts of time during this time period (data not shown). Among the 53% of all young adult women eligible based on attained age to report their activity levels at age 25 years, risk was similarly reduced for those participating in strenuous activity (OR, 0.75; 95% CI, 0.43-1.30); participation in activity at age 35 years could not be reliably assessed because only 13% of young adult women were old enough at interview to answer this question. Regular participation in a sports team or group at the ages of 18 to 22 years was associated with a reduced risk of HL. Adjustment of the physical activity measures at different time points for all related variables (participation in strenuous physical activity in the past year, having been a member of a sports team or group in high school, and having been a member of a sports team or group at ages 18-22 years) did not alter the ORs substantially (data not shown).


View this table:
[in this window]
[in a new window]
  		Table 2. Adjusted ORs (95% CIs) for the association between strenuous physical activity and sports participation and risk of Hodgkin's lymphoma among women 19 to 44 and 45 to 79 years of age

 
In older women (Table 2), none of the physical activity measures was significantly associated with HL, although all point estimates of the OR were below unity. As with young women, most women (73%) who exercised strenuously before the reference period exercised for 10 to 12 months per year, and the risk of HL was similarly reduced for women who participated in strenuous physical activity at least twice a week for varying lengths of time before the reference period (data not shown). HL risk was not consistently associated with participation in strenuous physical activity at ages 25, 35, or 50 years in older women (data not shown).

Associations for EBV-Positive and EBV-Negative HL
The associations between body size or physical activity measures and HL risk did not seem to vary markedly by EBV presence in the tumor cells in young women (Table 3 ). However, associations of risk with adult height were slightly stronger and statistically significant only for EBV-negative HL (compared with all controls) whereas associations with strenuous physical activity seemed to be slightly stronger for EBV-positive HL. The small numbers of older women with EBV positive tumors (n = 13) limited our ability to assess associations in this age group (data not shown).


View this table:
[in this window]
[in a new window]
  		Table 3. Adjusted ORs (95% CIs) for the association between height, weight and physical activity and risk of Hodgkin's lymphoma by EBV presence in the tumor cells among women 19 to 44 years of age

 
Associations by Race/Ethnicity
In young adults, the relationships between body size and physical activity measures and HL risk did not significantly differ between whites (n = 204 cases; n = 204 controls) and non-whites (n = 49 cases; n = 50 controls), although the relationship between taller height and HL was stronger in non-whites, as previously reported (20). With the reference group of women <1.60 m in height, the adjusted OR (with 95% CI) for HL was 2.85 (0.89-9.11) in non-whites and 0.93 (0.46-1.87) in whites 1.60 to <1.65 m tall; 2.46 (0.63-9.68) in non-whites and 1.76 (0.89-3.47) in whites 1.65 to <1.70 m tall; and 6.57 (1.52-28.47) in non-whites and 1.62 (0.84-3.12) in whites ≥1.70 m tall. In older women, the small numbers of non-whites (n = 12 cases; n = 12 controls) precluded reliable statistical analyses.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Our study found associations of HL risk with various measures of body size, including height and BMI, and strenuous physical activity, even after adjustment for measures of childhood and adult social class. Whereas taller height was associated with a higher risk of HL in all women, the association between higher BMI and HL risk varied by age, with higher BMI conferring an increased risk in younger women and a decreased risk in older women. In addition, strenuous physical activity at various time points in adult life was consistently associated with a reduced risk of HL in women in both age groups.

Higher birth weight also seemed to increase HL risk in young adults and reduce the risk in older adults. The single previous study of infant and childhood weight and HL risk reported that HL patients were significantly heavier at birth and at ages 10 and 12 years than controls matched on age, sex, and social class (5). In addition, our findings of a positive association of taller childhood and adult height with risk of HL are consistent with prior studies of males and females, in whom HL has been associated with taller height in childhood (5, 6), especially at ages 10 and 12 years (5), at age >13 years (6), and in adulthood (7, 8). However, two studies (9, 30) did not find an association between height and HL risk.

Higher BMI, including levels considered healthy by the WHO (<25 kg/m2), was linked to elevated HL risk in young women, although there was no apparent trend toward increasing HL risk with higher quartiles of BMI. In contrast, for older women, being overweight was associated with a lower risk of HL. The few previous studies of BMI with HL risk found no association in women (10-12) but two studies (9, 10) found an association between obesity and HL in men. In a nested case-control study of college alumni, men who were overweight or obese at baseline had an almost 2-fold increased risk of HL compared with living age-matched classmates (9). In persons with a hospital discharge of obesity (defined as BMI ≥28.6 kg/m2), males had a 3-fold higher incidence of HL whereas women (for whom obesity was defined as a BMI ≥30.0 kg/m2) did not have an elevated incidence of HL (10).

Recent strenuous physical activity, as well as sports team membership at ages 18 to 22 years, was associated with decreased risks for HL significantly in young adult women and nonsignificantly in older women. Strenuous activity throughout adult life also was associated with a nonsignificantly reduced risk of HL and significantly reduced risk of the EBV-positive variant in young adults. To our knowledge, the association between physical activity and HL risk has been examined in only one prior study (13). In a cohort of college students, participation in intramural or varsity sports ≥5 hours per week early in college was associated with a nonsignificantly reduced risk of developing HL during follow-up (age- and sex-adjusted hazard ratio, 0.73; P = 0.34; ref. 13). However, this study was unable to assess potential social class confounding characteristics or the level of physical activity in later life as it might relate to HL risk.

Most exposures previously tied to HL risk in women involve childhood infection or adult reproductive experiences (3, 4, 31). Based on these associations and present ideas about HL etiology, anthropometric measures and physical activity could be related to HL pathogenesis through mechanisms involving the immune response and/or steroid or metabolic hormone functions, although the pathways through which these factors may affect lymphoma development remain poorly understood. Physical activity could reduce HL risk by increasing the activity of natural killer cells (15, 32, 33) or by reducing inflammation (34). It also could decrease bioavailable insulin and insulin-like growth factors (15, 16), which stimulate cell turnover in most tissues and inhibit cell death (16, 32), and/or levels of endogenous sex hormones (16, 32, 33), which may affect HL pathogenesis indirectly through their influences on immune function (35). If, as suggested by some previous studies, EBV-positive HL patients have disordered immunity relative to EBV-negative HL patients (36, 37) and controls (38), then the effects of physical activity on immune function could be more beneficial toward the prevention of EBV-positive HL. Higher BMI may be associated with a higher risk for HL, at least in younger women, via the same biological mechanisms. In particular, high BMI could influence risk of HL by triggering higher levels of the cytokine interleukin-6 (39), insulin resistance, compensatory hyperinsulinemia, or increased production of growth factors, including estrogens (14); all of these mechanisms are thought to be important for other, mostly reproductive, malignancies in women. Our unexpected finding that being overweight reduces the risk for HL in older women is difficult to explain biologically. Given that response rates were lower in older cases due, in part, to poorer survival and that HL survival seems to be influenced by BMI (40), it is possible that our results in older women are biased due to selection for surviving HL cases with higher BMI.

The relationship between taller adult height and elevated risk for HL could involve several mechanisms. First, nascent HL tumors may be promoted by higher circulating levels of insulin-like growth factors and other growth hormones in taller women (41, 42). In one study, patients treated during childhood and early adulthood with human pituitary growth hormone, which raises the serum concentration of insulin-like growth factors, had 11-fold higher risks of HL mortality compared with the general population, although this finding was based on only two cases of HL (43). Height and HL could share common genetic determinants, as height is known to be influenced strongly by genes (41), and HL has been associated with genetic factors (44-46). In addition, taller height could reflect better nutrition (41, 47), which, like HL risk, is likely related to higher childhood socioeconomic status (2, 3). Similarly, the observed association of height and HL risk could reflect the effect of other uncontrolled socioeconomic factors, particularly given the stronger effect in nonwhites, for whom we previously showed stronger HL risks with several childhood socioeconomic characteristics (20). More frequent childhood exposure to infections, including Helicobacter pylori, may lead to ameliorated immune protection against HL while stunting growth (41, 42).

The strengths of our study include its population basis, uniformly re-reviewed histologic diagnoses, relatively high response rates, and detailed data to adjust for confounding. However, the study also has some limitations. First, risk factor data were self-reported and therefore subject to recall bias. Analyses of other variables from this data set (4) have not provided evidence of recall bias but it is possible that the findings for birth weight are biased, as one study found differential measurement error between breast cancer cases and controls despite the high correlation between self-reported and birth record birth weight (cases, r = 0.83; controls, r = 0.80; ref. 48). Second, our childhood height information was relative and provides only broad estimations of associated risk, although we considered it likely that respondents would recall their relative childhood height more accurately than their absolute height. Third, in certain age groups, controls were better educated than regional age- and race/ethnicity-specific census data would predict, although this bias was not large and had a small, mostly attenuating, effect on measures of association with social class and reproductive factors (49). Fourth, the association of strenuous physical activity 1 year before diagnosis with decreased risk could reflect reduced physical activity in patients due to symptoms of incipient HL. However, a lower risk for HL was noted among women who played sports in high school and during the ages of 18 through 22 years and exercised strenuously throughout adult life, suggesting that this inverse association with HL risk is not only attributable to prediagnostic changes in exercise patterns. Nevertheless, we cannot rule out the possibility of selection bias. Fifth, the measure created to summarize strenuous physical activity throughout life was inexact, as women could exercise as few as eight times per year in the years queried and still be considered active. However, in our study, women who were strenuously active at least 1 month tended to be active 10 to 12 months in each time period. Sixth, because this study only measured strenuous physical activity, we could not evaluate the combined or independent effect of less strenuous or occupational physical activity, alone or with strenuous physical activity, on HL risk at each time point or throughout life. Seventh, our study enrolled a small number of older women due to incidence patterns and the low response rate, primarily due to mortality. Thus, the effect of any risk factor also associated with survival would be underestimated in this age group. On the other hand, the finding that higher BMI was associated with lower risk for HL in older women may have resulted from BMI being related to survival (i.e., older women/cases with low BMI may be less likely to survive; ref. 40). Lastly, analyses of risks for EBV-related HL, involving the 79% of cases for whom specimens could be obtained, were affected by limited statistical power due to the low prevalence of EBV-positive HL in our study population (24, 26). To overcome these limitations, it would be ideal to examine the associations of body size and physical activity with risk of HL in a prospective cohort, although the low incidence of HL makes such a study design impractical for research on this lymphoma.

In conclusion, we have found that body size and strenuous physical activity are associated with HL risk in women. The positive associations of HL with higher childhood and adult height, which are consistent with previous findings, may suggest leads for future studies addressing HL risk associated with childhood nutrition and/or genetic susceptibility related to height; similarly, the novel findings of a higher risk of HL in young adults with higher, but healthy, BMI values and the opposite findings in older adults need further investigation. Our evidence that strenuous physical activity significantly reduces the risk of developing HL in women not only adds to the evidence in support for the health benefits of exercise but also may provide clues in the effort to elucidate HL pathogenesis in general, and for EBV-positive HL in particular. Better understanding of the associations of body size and physical activity with HL development will require exploring risks related to less strenuous and occupational physical activity, in addition to strenuous physical activity, at various time points and throughout life, and pursuing the biological mechanisms underlying any associations.


   Acknowledgments
 
We thank Scarlett Lin Gomez for her contributions to this study.


   Footnotes
 
Grant support: National Cancer Institute grants R03 CA106014 (S.L. Glaser and T.H. Keegan), R29 CA50381 (S.L. Glaser and R.F. Dorfman), R03 CA63245 (S.L. Glaser and R.F. Ambinder), and P50 CA96888 (R.F. Ambinder). The collection of cancer incidence data used in this study was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract N01-PC-35136 awarded to the Northern California Cancer Center and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement #U55/CCR921930-02 awarded to the Public Health Institute.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Note: The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California, Department of Health Services, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred.

Received 1/11/06; revised 3/15/06; accepted 4/25/06.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1973-1999. Bethesda (MD): National Cancer Institute; 2002.
  2. Mueller N. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. 2nd ed. New York (NY): Oxford University Press; 1996. p. 893–919.
  3. Mueller N, Grufferman S. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, editors. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 61–77.
  4. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Reproductive risk factors in Hodgkin's disease in women. Am J Epidemiol 2003;158:553–63.[Abstract/Free Full Text]
  5. Isager H, Andersen E. Pre-morbid factors in Hodgkin's disease. I. Birth weight and growth pattern from 8 to 14 years of age. Scand J Haematol 1978;21:250–5.[Medline]
  6. Pui CH, Dodge RK, George SL, Green AA. Height at diagnosis of malignancies. Arch Dis Child 1987;62:495–9.[Abstract]
  7. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981;304:135–40.[Abstract]
  8. Hancock BW, Mosely R, Coup AJ. Height and Hodgkin's disease (letter). Lancet 1976;2:1364.[Medline]
  9. Paffenbarger RS, Jr., Wing AL, Hyde RT. Characteristics in youth indicative of adult-onset Hodgkin's disease. J Natl Cancer Inst 1977;58:1489–91.[Medline]
  10. Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13–21.[CrossRef][Medline]
  11. Bosetti C, Dal Maso L, Negri E, et al. Re: Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005;97:860–1.[Free Full Text]
  12. Chang ET, Hjalgrim H, Smedby KE, et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005;97:210–8.[Abstract/Free Full Text]
  13. Paffenbarger RS, Lee I, Wing AL. The influence of physical activity in the incidence of site-specific cancers in college alumni. Adv Exp Med Biol 1992;322:7–15.[Medline]
  14. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565–74.[CrossRef][Medline]
  15. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287–301.[Abstract/Free Full Text]
  16. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002;132:3456–64S.
  17. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 1994;52:37–50.[Medline]
  18. Shephard RJ, Shek PN. Associations between physical activity and susceptibility to cancer: possible mechanisms. Sports Med 1998;26:293–315.[CrossRef][Medline]
  19. Glaser SL, Clarke CA, Stearns CB, Dorfman RF. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma 2001;42:997–1004.[Medline]
  20. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer 2002;98:110–7.[CrossRef][Medline]
  21. Paffenbarger RS, Jr., Wing AL, Hyde RT, Jung DL. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol 1983;117:245–57.[Abstract/Free Full Text]
  22. International Agency for Research on Cancer. Weight control and physical activity. Lyon: IARC Press; 2002.
  23. Ambinder RF, Weiss LM. Association of Epstein-Barr virus with Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, editors. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 79–98.
  24. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375–82.[CrossRef][Medline]
  25. Flavell KJ, Biddulph JP, Constandinou CM, et al. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 2000;14:748–53.[CrossRef][Medline]
  26. Jarrett RF, Krajewski AS, Angus B, et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003;56:811–6.[Abstract/Free Full Text]
  27. Murray PG, Constandinou CM, Crocker J, Young LS, Ambinder RF. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. Blood 1998;92:2477–83.[Abstract/Free Full Text]
  28. Murray PG, Swinnen LJ, Flavell JR, et al. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. Hum Pathol 2001;32:963–9.[CrossRef][Medline]
  29. Glaser SL, Keegan TH, Clarke CA, et al. Smoking and Hodgkin lymphoma risk in women United States. Cancer Causes Control 2004;15:387–97.[CrossRef][Medline]
  30. La Vecchia C, Negri E, Parazzini F, et al. Height and cancer risk in a network of case-control studies from northern Italy. Int J Cancer 1990;45:275–9.[Medline]
  31. Kravdal O, Hansen S. Hodgkin's disease: the protective effect of childbearing. Int J Cancer 1993;55:909–14.[Medline]
  32. McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 1998;9:487–509.[CrossRef][Medline]
  33. Woods JA. Exercise and resistance to neoplasia. Can J Physiol Pharmacol 1998;76:581–8.[CrossRef][Medline]
  34. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005;45:1563–9.[Abstract/Free Full Text]
  35. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000;85:1648–57.[Abstract/Free Full Text]
  36. Frisan T, Sjoberg J, Dolcetti R, et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995;86:1493–501.[Abstract/Free Full Text]
  37. Chang ET, Zheng T, Lennette ET, et al. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis 2004;189:2271–81.[CrossRef][Medline]
  38. Levin L, Lennette ET, Ambinder RF, Chang ET, Rubertone M, Mueller NE. Prediagnosis Epstein-Barr virus serologic patterns in relation to the molecular status of Hodgkin's lymphoma in young adults. In: Abstract and poster at American Association for Cancer Research International Conference on Molecular and Genetic Epidemiology of Cancer; January 2003; Waikoloa, Hawaii; January 2003.
  39. Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 2004;103:3216–21.[Abstract/Free Full Text]
  40. Landgren O, Andren H, Nilsson B, Ekbom A, Bjorkholm M. Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial? Ann Oncol 2005;16:838–40.[Free Full Text]
  41. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23:313–42.[Free Full Text]
  42. Okasha M, Gunnell D, Holly J, Davey Smith G. Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 2002;16:225–41.[CrossRef][Medline]
  43. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002;360:273–7.[CrossRef][Medline]
  44. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 1994;54:497–505.[Medline]
  45. Goldin LR, McMaster ML, Ter-Minassian M, et al. A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet 2005;42:595–601.[Free Full Text]
  46. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 2005;365:2216–24.[CrossRef][Medline]
  47. Silventoinen K. Determinants of variation in adult body height. J Biosoc Sci 2003;35:263–85.[CrossRef][Medline]
  48. Sanderson M, Williams MA, White E, et al. Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol 1998;147:136–40.[Abstract/Free Full Text]
  49. Glaser SL, Clarke CA, Keegan TH, et al. Attenuation of social class and reproductive risk factor associations for Hodgkin lymphoma due to selection bias in controls. Cancer Causes Control 2004;15:731–9.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
U. Lim, L. M. Morton, A. F. Subar, D. Baris, R. Stolzenberg-Solomon, M. Leitzmann, V. Kipnis, T. Mouw, L. Carroll, A. Schatzkin, et al.
Alcohol, Smoking, and Body Size in Relation to Incident Hodgkin's and Non-Hodgkin's Lymphoma Risk
Am. J. Epidemiol., September 15, 2007; 166(6): 697 - 708.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keegan, T. H.M.
Right arrow Articles by Ambinder, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keegan, T. H.M.
Right arrow Articles by Ambinder, R. F.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation